Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, Yang H, Carbone M

Open source

DOI
10.1093/carcin/bgu227
Published
2015 Jan
Container
Carcinogenesis
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/carcin/bgu227,
  title = {Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.},
  author = {Baumann F and Flores E and Napolitano A and Kanodia S and Taioli E and Pass H and Yang H and Carbone M},
  year = {2015},
  journal = {Carcinogenesis},
  doi = {10.1093/carcin/bgu227},
  url = {https://doi.org/10.1093/carcin/bgu227}
}

RIS

TY  - JOUR
TI  - Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
AU  - Baumann F
AU  - Flores E
AU  - Napolitano A
AU  - Kanodia S
AU  - Taioli E
AU  - Pass H
AU  - Yang H
AU  - Carbone M
PY  - 2015
JO  - Carcinogenesis
DO  - 10.1093/carcin/bgu227
UR  - https://doi.org/10.1093/carcin/bgu227
ER  - 

APA

F, B., E, F., A, N., S, K., E, T., H, P., H, Y., & M, C. (2015). Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.. Carcinogenesis. https://doi.org/10.1093/carcin/bgu227

Source records